01
Target
Start from the protein you want to modulate. The biology comes first.
From a biological target to a characterized, novel protein. In weeks.
Lagomics combines generative protein design with multiplexed experimental validation to deliver novel candidates with binding affinity, functional activity, and stability data, faster than any lab-only or computation-only approach.
The design-validate loop
Target-first design, closed with measured binding. Not computation alone. Not a validation service.
02
Design
Generative models produce novel sequences engineered to bind your target. Created from scratch.
03
Validate
Thousands of candidate-target interactions measured in one pooled experiment.
04
Deliver
A characterized candidate with binding, activity, and stability data. Ready for your pipeline.
Applications
One design engine. Markets that need novel proteins with real mechanistic data.
Cosmetic & personal care actives
Novel peptide actives with real mechanistic data: binding affinity against a defined target, not just a bioactivity claim. Built for ingredient houses and brands.
Therapeutic targets
The same design engine addresses disease-relevant targets. Currently exploring applications in women's health with federal research support.
Activate Fellowship · MIT Engine · NVIDIA · Based at MBC Biolabs
Have a target in mind?
Tell us what you want to modulate. We'll tell you if a pilot makes sense within one call.